Open AccessPD10-10 A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL EVALUATING OVERALL SURVIVAL IN PATIENTS WITH PRIMARY BONE METASTATIC PROSTATE CANCER (MPCA) RECEIVING EITHER ANDROGEN DEPRIVATION THERAPY (ADT) OR ADT COMBINED WITH CONCURRENT RADIATION THERAPY TO THE PROSTATE, FINAL DATA FROM THE HORRAD TRIAL
Author(s) -
Liselotte M.S. Boevé,
Maarten C.C.M. Hulshof,
André N. Vis,
Koos Zwinderman,
Jos W. R. Twisk,
K.P.J. Delaere,
Jeroen van Moorselaar,
Paul C.M.S. Verhagen,
George van Andel
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.02.620
Subject(s) - medicine , prostate cancer , androgen deprivation therapy , randomized controlled trial , radiation therapy , bone metastasis , oncology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom